Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Immune checkpoint inhibitors
Page 1 of 2 ( 51 items )
<<
1
2
>>
1
When new therapies arrive, we should think more: The unseen challenges of immunotherapy-induced remodeling
11/21/2025 3:54:19 AM |
Browse: 12 |
Download: 24
2
Endoscopic insights into digestive-related adverse effects of immune checkpoint inhibitors: A narrative review
7/9/2025 7:00:43 AM |
Browse: 50 |
Download: 191
3
Early identification and multidisciplinary management of immune checkpoint inhibitors associated colitis can improve patient outcomes
12/27/2024 1:37:13 PM |
Browse: 104 |
Download: 454
4
Clinical evaluation of sintilimab in conjunction with bevacizumab for advanced colorectal cancer with microsatellite stable-type after failure of first-line therapy
9/28/2024 4:34:28 AM |
Browse: 146 |
Download: 642
5
Medical dilemma: Programmed death 1 blockade (sintilimab) therapy in patients suffering from tumours combined with psoriasis
9/19/2024 12:00:22 PM |
Browse: 122 |
Download: 500
6
Gastric cancer liver metastasis will reduce the efficacy of immunotherapy
9/18/2024 11:53:42 AM |
Browse: 115 |
Download: 430
7
Immune-related adverse events associated with immune checkpoint inhibitors for advanced gastric and gastroesophageal junction cancer: A meta-analysis
2/15/2023 12:44:08 AM |
Browse: 356 |
Download: 1362
8
Immune checkpoint inhibitor-mediated colitis is associated with cancer overall survival
10/18/2022 8:29:59 AM |
Browse: 431 |
Download: 1312
9
Immune checkpoint inhibitor-associated arthritis in advanced pulmonary adenocarcinoma: A case report
9/29/2022 9:17:29 AM |
Browse: 451 |
Download: 1452
10
Comment on “Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy”
8/1/2022 9:20:54 AM |
Browse: 577 |
Download: 1517
11
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment
7/27/2022 1:17:37 PM |
Browse: 724 |
Download: 1474
12
Necessity of neutrophil-to-lymphocyte ratio monitoring for hypothyroidism using nivolumab in patients with cancer
7/22/2022 9:38:18 AM |
Browse: 542 |
Download: 1404
13
Advances and effectiveness of the immunotherapy after liver transplantation
6/27/2022 9:34:47 AM |
Browse: 600 |
Download: 1402
14
Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances
6/22/2022 8:29:42 AM |
Browse: 612 |
Download: 1343
15
Recent advances in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
5/25/2022 8:33:35 AM |
Browse: 502 |
Download: 1189
16
Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials
5/24/2022 12:41:49 PM |
Browse: 515 |
Download: 1027
17
Neoadjuvant treatment in non-small cell lung cancer: New perspectives with the incorporation of immunotherapy
5/24/2022 12:41:49 PM |
Browse: 496 |
Download: 1463
18
Tsunami of immunotherapy reaches mesothelioma
4/22/2022 8:49:02 AM |
Browse: 528 |
Download: 1308
19
Anti-programmed death 1 antibody in the treatment of coexistent Mycobacterium fortuitum and lung cancer: A case report
4/21/2022 11:35:30 AM |
Browse: 389 |
Download: 1005
20
Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy
2/23/2022 3:51:55 PM |
Browse: 548 |
Download: 1735
21
Tumor-related cytokine release syndrome in a treatment-naïve patient with lung adenocarcinoma: A case report
2/11/2022 5:55:20 AM |
Browse: 504 |
Download: 1511
22
Update on the treatment of metastatic renal cell carcinoma
1/22/2022 6:17:12 AM |
Browse: 549 |
Download: 1093
23
Targets of immunotherapy for hepatocellular carcinoma: An update
1/21/2022 8:16:14 AM |
Browse: 529 |
Download: 1104
24
Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons
1/11/2022 12:11:23 AM |
Browse: 551 |
Download: 1528
25
New era of electrochemotherapy in treatment of liver tumors in conjunction with immunotherapies
12/24/2021 9:48:20 AM |
Browse: 526 |
Download: 1183
26
Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification
12/17/2021 8:56:01 AM |
Browse: 625 |
Download: 1396
27
Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival
11/6/2021 4:43:07 AM |
Browse: 673 |
Download: 1552
28
Dynamic changes in the radiologic manifestation of a recurrent checkpoint inhibitor related pneumonitis in a non-small cell lung cancer patient: A case report
10/21/2021 8:44:04 AM |
Browse: 568 |
Download: 1237
29
Immune checkpoint inhibitor-related hepatotoxicity: A review
8/25/2021 2:11:51 AM |
Browse: 723 |
Download: 1528
30
Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease
8/14/2021 11:08:13 AM |
Browse: 713 |
Download: 1193
31
Current cancer therapies and their influence on glucose control
7/12/2021 5:45:28 AM |
Browse: 641 |
Download: 1493
32
Efficacy of artificial liver support system in severe immune-associated hepatitis by camrelizumab: A case report and review of literature
5/26/2021 9:58:02 AM |
Browse: 609 |
Download: 1552
33
Atezolizumab-induced anaphylactic shock in a patient with hepatocellular carcinoma undergoing immunotherapy: A case report
5/14/2021 9:21:56 AM |
Browse: 620 |
Download: 1778
34
Myeloid-derived suppressor cells in gastrointestinal cancers: A systemic review
1/7/2021 10:14:28 AM |
Browse: 637 |
Download: 1242
35
Practice change in the management of metastatic urothelial carcinoma after ASCO 2020
12/18/2020 12:27:09 PM |
Browse: 707 |
Download: 1551
36
Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis
11/26/2020 8:54:27 AM |
Browse: 814 |
Download: 1601
37
Deep diving in the PACIFIC: Practical issues in stage III non-small-cell lung cancer to avoid shipwreck
11/18/2020 2:20:37 PM |
Browse: 961 |
Download: 1636
38
Steroid-responsive pancreatitides
8/25/2020 9:45:46 AM |
Browse: 812 |
Download: 1876
39
Severe steroid refractory gastritis induced by Nivolumab: A case report
4/28/2020 8:04:31 AM |
Browse: 1070 |
Download: 2219
40
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
8/7/2019 7:09:17 AM |
Browse: 1108 |
Download: 1898
41
Antibiotics and immunotherapy in gastrointestinal tumors: friend or foe?
6/6/2019 5:44:00 PM |
Browse: 1084 |
Download: 2018
42
Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
5/28/2019 9:29:42 AM |
Browse: 1082 |
Download: 2121
43
Immune checkpoint inhibitor-induced colitis: A comprehensive review
2/26/2019 9:05:11 AM |
Browse: 951 |
Download: 1747
44
Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
9/20/2018 2:33:54 AM |
Browse: 1065 |
Download: 1893
45
Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer
8/27/2018 7:22:43 AM |
Browse: 1223 |
Download: 1740
46
Immunotherapies in sarcoma: Updates and future perspectives
4/7/2017 8:24:12 AM |
Browse: 1178 |
Download: 1708
47
Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography?
2/27/2017 6:19:00 PM |
Browse: 1157 |
Download: 1711
48
From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis
2/8/2017 3:24:00 PM |
Browse: 1181 |
Download: 1794
49
Immune checkpoint therapy for pancreatic cancer
11/18/2016 3:13:00 PM |
Browse: 1233 |
Download: 1685
50
Immunobiology of hepatocarcinogenesis: Ways to go or almost there?
8/10/2016 3:41:00 PM |
Browse: 1407 |
Download: 2033
Page 1 of 2 ( 51 items )
<<
1
2
>>
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345